Further, many employers (as high as 59% of employers with at least 5,000 workers) that offered such coverage said that use of GLP-1 medications was higher than expected, and 66% of the largest employers said that covering such drugs for weight loss had a significant impact on their health plans prescription drug spending
Obesity: global epidemiology and pathogenesis
After years of struggling with traditional diets or hitting metabolic plateaus, you may finally feel a sense of hope with modern medications
Once available, cagrilintide may be particularly suitable for patients who experience significant GI side effects with GLP-1 medications, those seeking an alternative mechanism for appetite control, or as part of combination therapy for enhanced results
epidermidis compound responsible for GLP-1 stimulatory activity To identify the bacterial component responsible for GLP-1 secretion in vitro and for metabolic disease marker modulation in vivo , we performed size fractionation studies on conditioned supernatants of S